Financials

  • Market Capitalization 234.56 M
  • Employee 106
  • Founded 2019
  • CEO N/A
  • Website www.artivabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00VPZJ0F9
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.81
Relación precio/flujo de caja
262.27

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3462
SRZN
Surrozen, Inc. - Common Stock
21.98 USD+0.46%-3.34%-5.22%+164.18%255.20 M USD
3479
RNAC
Cartesian Therapeutics, Inc. - Common Stock
8.48 USD-1.62%-14.69%-1.62%-7.42%249.16 M USD
3499
ACIU
AC Immune SA - Common Stock
2.39 USD-0.83%-3.24%+0.84%+16.59%243.16 M USD
3517
FULC
Fulcrum Therapeutics, Inc. - Common Stock
3.58 USD-0.28%-1.38%+1.42%-54.57%238.55 M USD